Understanding Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Treatment Options and Practical Considerations

This opening segment introduces low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) and establishes the anatomic and diagnostic vocabulary the rest of the program relies on.

This segment explains how pathology from a transurethral resection of bladder tumor (TURBT) determines grade, stage, and risk category.

This segment introduces the patient case that anchors the program: an older retired teacher originally diagnosed with a low-grade Ta bladder tumor after noticing blood in his urine.

This segment reviews standard management for newly diagnosed intermediate-risk non-muscle invasive bladder cancer.

This segment returns to the patient case to explore alternatives to repeat surgery.

This segment compares the practical logistics of delivering intravesical therapies and encourages clinics to identify treatment champions among pharmacy, clinic, and provider staff.

This segment addresses recognizing and managing adverse events, with nurses described as the care team's eyes on the ground.

This closing segment follows the patient into surveillance as he and his wife worry about recurrence.